about
Molecular mechanisms of inflammation and tissue injury after major trauma--is complement the "bad guy"?On the Functional Overlap between Complement and Anti-Microbial PeptidesDisruption of the C5a receptor gene increases resistance to acute Gram-negative bacteremia and endotoxic shock: opposing roles of C3a and C5a.Glyceraldehyde-3-phosphate dehydrogenase (GAPDH) prevents lipopolysaccharide (LPS)-induced, sepsis-related severe acute lung injury in mice.Beneficial and detrimental effects of plasmin(ogen) during infection and sepsis in mice.Complement activation in emergency department patients with severe sepsisSphingosine kinase 1 mediation of expression of the anaphylatoxin receptor C5L2 dampens the inflammatory response to endotoxinComplement in animal development: unexpected roles of a highly conserved pathway.Nrf2 is a critical regulator of the innate immune response and survival during experimental sepsis.Elimination of C5aR prevents intestinal mucosal damage and attenuates neutrophil infiltration in local and remote organs.Adenovirus-mediated in vivo silencing of anaphylatoxin receptor C5aR.Cutting edge: the membrane attack complex of complement is required for the development of murine experimental cerebral malaria.Properdin levels in human sepsis.Anti-inflammatory strategies for the treatment of sepsis.C5a-induced gene expression in human umbilical vein endothelial cells.Disturbed homeostasis of lung intercellular adhesion molecule-1 and vascular cell adhesion molecule-1 during sepsis.The enigma of sepsis.A key role of C5a/C5aR activation for the development of sepsis.MyD88-dependent production of IL-17F is modulated by the anaphylatoxin C5a via the Akt signaling pathway.Thrombin-activatable procarboxypeptidase B regulates activated complement C5a in vivo.MHC class I-specific antibody binding to nonhematopoietic cells drives complement activation to induce transfusion-related acute lung injury in miceManipulation of the complement system for benefit in sepsis.Alternative Pathway Inhibition by Exogenous Factor H Fails to Attenuate Inflammation and Vascular Leakage in Experimental Pneumococcal Sepsis in Mice.Role of Complement C5 in Experimental Blunt Chest Trauma-Induced Septic Acute Lung Injury (ALI).An essential role for complement C5a in the pathogenesis of septic cardiac dysfunction.Acute lung injury and the acute respiratory distress syndrome: four decades of inquiry into pathogenesis and rational management.Emerging drugs for the treatment of sepsis.Neutrophils orchestrate their own recruitment in murine arthritis through C5aR and FcγR signaling.The role of complement, C5a and its receptors in sepsis and multiorgan dysfunction syndrome.C5 deficiency and C5a or C5aR blockade protects against cerebral malariaTherapeutic potential of HMGB1-targeting agents in sepsis.Is CaMKII a link between inflammation and hypertrophy in heart?Complement component C5a mediates hemorrhage-induced intestinal damageRenal dysfunction in burns: a review.Inhibition of complement C5a prevents breakdown of the blood-brain barrier and pituitary dysfunction in experimental sepsisImmunomodulatory and Antimicrobial Activity of Babassu Mesocarp Improves the Survival in Lethal Sepsis.Sepsis, apoptosis and complement.Anticomplement therapy.Experimental therapeutic strategies for severe sepsis: mediators and mechanisms.Attenuation of IgG immune complex-induced acute lung injury by silencing C5aR in lung epithelial cells.
P2860
Q26825724-0B610A39-3746-49FB-A168-D03D4E794192Q28082379-B6B6F08F-7291-4821-96A5-D0D148F3CF1CQ33377675-133DCC56-E4C8-4616-A252-AC298DF3F472Q33718932-E8AD3367-75B4-42CE-8DBE-76892D1B1679Q34024041-56B973FF-D169-4E84-AF9A-B16BE1F29417Q34054994-0F320659-1D94-4714-87C6-A1A9DED2C148Q34166226-C19B9B7E-EC9A-4052-BFDB-CD6441533E0FQ34344142-09ACBB68-E914-4116-A314-8C2F6DFE2328Q34498927-B8588AC6-68C2-4A06-93D7-D90DAF4CB11BQ34509114-ED98DF30-C1CF-43B8-8A78-0B33C164C58FQ34795237-A68618A2-4E79-4D05-B920-2186C1E4257DQ35032418-49808F18-0014-4758-9564-1042C3791E33Q35037612-B25539C1-3A78-4221-AF80-C78C892D9331Q35093632-74F4CFB5-745B-4D40-B6EC-D24D95740517Q35094695-7131B988-6A66-465D-8855-EE19B99B99F5Q35097439-862F60C0-3993-41C8-A241-646A3D584DBEQ35202458-DE2A47F6-696E-4D1E-AD80-ECDBB02D2863Q35213810-967F3B27-B74C-4F05-B875-627F3748C4B9Q35609638-84B1B97D-11F4-437D-B378-AF1F65D550B0Q35642856-054D0804-B285-4982-A977-D36DCD8EC8F1Q35669060-D0B1F41E-170C-4001-A957-1231E5A42ECEQ35829670-5E215F1B-7199-4249-988E-AE76986D299CQ35922386-66944F93-6BAB-4700-99B0-63E0592CE1ADQ36082652-2D43A26E-5A89-4A53-9CC2-9986969758ACQ36227873-A032181D-D29C-4519-B1B5-EDF71ED96F23Q36261456-8C974B5B-FA5A-44E1-BA3B-3B747756EDF8Q36407391-91C2BE39-370A-4627-8868-9C73CEF41602Q36414844-95E527FE-DF4F-4796-8E82-AD23EDE6FCABQ36533660-0C11FE23-3329-4A10-9B35-35306A3E22FBQ36640015-A6D1DF38-7D48-4A20-AB00-1AA16062C0B2Q36981872-90CB9CCC-27A8-4C52-AD45-0CD18E634BE8Q37064322-3F4F3F6E-0D46-475E-B177-3DDB5437CC25Q37087719-8FDD90BA-6F69-4157-83A8-AE0CAB92A2F0Q37089078-0B005EC9-3AB4-47A0-B630-8CFEE2E40361Q37206724-88DEA7E8-FBCA-4FC2-9549-49686701C67EQ37222877-4575EF0F-4529-4534-BD9F-BB39B6104791Q37291833-F1693061-10C2-4C8F-8780-A3823AC091AEQ37307880-97D73318-8533-4856-8ABF-05B4B6961A4DQ37348491-5A06DC5B-1C5C-40E3-91D2-2737520F0072Q37415851-2E144E1D-2EC5-475C-8B9D-4F87202A1BD5
P2860
description
2002 nî lūn-bûn
@nan
2002 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Increased C5a receptor expression in sepsis.
@ast
Increased C5a receptor expression in sepsis.
@en
Increased C5a receptor expression in sepsis.
@nl
type
label
Increased C5a receptor expression in sepsis.
@ast
Increased C5a receptor expression in sepsis.
@en
Increased C5a receptor expression in sepsis.
@nl
prefLabel
Increased C5a receptor expression in sepsis.
@ast
Increased C5a receptor expression in sepsis.
@en
Increased C5a receptor expression in sepsis.
@nl
P2093
P2860
P356
P1476
Increased C5a receptor expression in sepsis.
@en
P2093
Carl L Pierson
Christoph W Strey
Dimitrios Mastellos
Ines J Laudes
John D Lambris
Katie A Keller
Maciej M Markiewski
Niels C Riedemann
Ren-Feng Guo
Thomas A Neff
P2860
P304
P356
10.1172/JCI0215409
P407
P577
2002-07-01T00:00:00Z